German-based Wellster, a digital healthcare platform that provides everyday health status to consumers and solves health queries, helping consumers stay healthy in their fast-paced lives, raised USD 60 million on 18th January 2022.
Investors: The investment round was led by Claret Capital and Mangrove Capital Partners. There have already been many investments in femtech and healthtech companies from both institutions.
Purpose of funding: This funding will be used in conjunction with the previous round (USD 40 million raised in 2021) to launch a women’s healthcare platform alongside their men’s healthcare platform, Spring.
About Wellster
Founded in 2018 by Manuel Nothelfer, and Nico Hribernik, Wellster is located in Munich, Germany. Wellster is a digital healthcare platform that provides everyday health status to consumers and solves health queries, helping consumers stay healthy in their fast-paced lives. The startup has made major platforms under its mission. The platforms include GoSpring & mySpring for men’s health, helloeasy.de for mental health, easydrema.de for skin health, and easy-testen.de for medical tests and queries.
The startup’s primary goal is to promote easy access to medical care while prioritizing the needs of patients. Intimate healthcare queries are the company’s focus, which creates new platforms. By doing so, the startup provides health consultation where people can speak without stress or peer pressure. Patients can submit questionnaires or schedule video consultations on the platform. Following that, a doctor issues prescriptions online and sends them discretely to the patient’s home. The startup ensures the privacy of its customers with almost accuracy in the process.
What the founders have to say
“The funding round comes at a key moment in our development,” said Manuel Nothelfer, co-founder at Wellster Healthtech Group.
“It cements our ambition to continue our established leadership in the European market and expand our offering to more people in need of personalized, in-home healthcare services.”
“Our multi-platform service allows us to tailor personalized treatments to people with different types of healthcare needs. This allows us to address better individual health problems, which ultimately leads to higher treatment success rates, as well as more trust among patients,” said Nico Hribernik, co-founder at Wellster Healthtech Group.
What the investor has to say
“Given its sheer size, the potential for value creation in the healthcare sector is second to none. What makes Wellster particularly attractive is the combination of a compelling direct-to-consumer health proposition and a solid team with the ambition to disrupt the huge European health market. Both are great fits with our investment thesis,” said Hans-Juergen Schmitz, Managing Partner at Mangrove Capital Partners.
For more extensive analysis and Market Intelligence reports feel free to approach us or visit our website: Venture Capital Market Intelligence Reports | VCBay.
We try our 2022 best to fact-check and bring the best, well-researched, and non-plagiarized content to you. Please let us know
-if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback and thank you for stopping by!
Next Article
